These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36030334)

  • 1. Leveraging Patient Preference Information in Medical Device Clinical Trial Design.
    Rincon-Gonzalez L; Selig WKD; Hauber B; Reed SD; Tarver ME; Chaudhuri SE; Lo AW; Bruhn-Ding D; Liden B
    Ther Innov Regul Sci; 2023 Jan; 57(1):152-159. PubMed ID: 36030334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information.
    Benz HL; Saha A; Tarver ME
    Value Health; 2020 Mar; 23(3):294-297. PubMed ID: 32197723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration.
    Thomas M; Marshall DA; Sanchez AL; Bartlett SJ; Boonen A; Fraenkel L; Proulx L; Voshaar M; Bansback N; Buchbinder R; Guillemin F; Hiligsmann M; Richards DP; Richards P; Shea B; Tugwell P; Falahee M; Hazlewood GS
    Semin Arthritis Rheum; 2023 Feb; 58():152112. PubMed ID: 36372015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
    Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies.
    Ho M; Saha A; McCleary KK; Levitan B; Christopher S; Zandlo K; Braithwaite RS; Hauber AB;
    Value Health; 2016; 19(6):746-750. PubMed ID: 27712701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for measuring patient preferences: an update and future directions.
    Meara A; Crossnohere NL; Bridges JFP
    Curr Opin Rheumatol; 2019 Mar; 31(2):125-131. PubMed ID: 30624283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Oriented Research Competencies in Health (PORCH) for patients, healthcare providers, decision-makers and researchers: protocol of a scoping review.
    Mallidou AA; Frisch N; Doyle-Waters MM; MacLeod MLP; Ward J; Atherton P
    Syst Rev; 2018 Jul; 7(1):101. PubMed ID: 30025543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL.
    Vale CL; Cragg WJ; Cromarty B; Hanley B; South A; Stephens R; Sturgeon K; Gafos M
    Trials; 2018 Feb; 19(1):95. PubMed ID: 29415751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.
    Day S; Blumberg M; Vu T; Zhao Y; Rennie S; Tucker JD
    J Int AIDS Soc; 2018 Oct; 21 Suppl 7(Suppl Suppl 7):e25174. PubMed ID: 30334358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and public involvement (PPI) in UK surgical trials: a survey and focus groups with stakeholders to identify practices, views, and experiences.
    Crocker JC; Pratt-Boyden K; Hislop J; Rees S; Locock L; Olszowski S; Chant A; Treweek S; Cook JA; Woolfall K; Farrar N; Bostock J; Bulbulia R
    Trials; 2019 Feb; 20(1):119. PubMed ID: 30744684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholder Engagement in Planning the Design of a National Needs Assessment for Cardiovascular Disease Prevention and Management in Nepal.
    Archana S; Karmacharya BM; Rashmi M; Abhinav V; Meghnath D; Natalia O; Rajeev S; Prajjwal P; Annette F; David C; Swornim B; Roman XD; Donna S; Rajendra K
    Glob Heart; 2019 Jun; 14(2):181-189. PubMed ID: 31324373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs.
    Cook NS; Cave J; Holtorf AP
    Front Med (Lausanne); 2019; 6():82. PubMed ID: 31069227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Experience Information: Streamlining and Harmonizing the Collection of Patient Preference and Patient-Reported Outcomes Data.
    Reaney M; Rodriguez AM
    Pharmaceut Med; 2020 Oct; 34(5):309-314. PubMed ID: 33156510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
    Messner DA; Rabins P; Downing AC; Irizarry M; Foster NL; Al Naber J; Dabbous O; Fillit H; Gabler S; Krakauer R; Lotz D; Payzant E; Schneider L; Tyrone J; Van Amerongen D; Wuest D
    J Prev Alzheimers Dis; 2019; 6(1):20-26. PubMed ID: 30569082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ethical challenges and opportunities of implementing engagement strategies in health research.
    Salerno J; Coleman KJ; Jones F; Peters ES
    Ann Epidemiol; 2021 Jul; 59():37-43. PubMed ID: 33894383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis.
    Bywall KS; Veldwijk J; Hansson MG; Kihlbom U
    Patient; 2019 Jun; 12(3):297-305. PubMed ID: 30443897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials.
    Snyder C; Crossnohere N; King M; Reeve BB; Bottomley A; Calvert M; Thorner E; Wu AW; Brundage M;
    Clin Trials; 2022 Jun; 19(3):277-284. PubMed ID: 35094586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community engagement and involvement in Ghana: conversations with community stakeholders to inform surgical research.
    Kroese K; Ofori BA; Abdulai DR; Monahan M; Prah A; Tabiri S
    Res Involv Engagem; 2021 Jul; 7(1):50. PubMed ID: 34225824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness.
    Gobat NH; Gal M; Francis NA; Hood K; Watkins A; Turner J; Moore R; Webb SA; Butler CC; Nichol A
    Trials; 2015 Dec; 16():591. PubMed ID: 26715077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.